European Commission logo
English English
CORDIS - EU research results
CORDIS

Strengthening global cooperation and institutional capacities in sub-Saharan Africa to facilitate implementation of the GH EDCTP3 programme

Project description

Support to Africa Office to facilitate implementation of the GH EDCTP3 programme

The Global Health (GH) EDCTP3 Joint Undertaking has called for support for the EDCTP Africa Office (AO) located in Cape Town and hosted by the South African Medical Research Council under the EDCTP Association Secretariat. The EU-funded EDCTP Africa Office project will ensure optimal implementation and visibility of the GH EDCTP3 programme in sub-Saharan Africa (SSA). The AO will provide technical support, promote networking activities, ensure alignment of the funded activities and boost strategic partnerships. Through several activities, the project will contribute to accelerated product development for fighting target infectious diseases, facilitate preparedness against public health emergencies aligned with One Health, ensure close alignment with national research programmes, increase SSA countries’ participation, and engage industry and private entities in product development and clinical trials.

Objective

This proposal is in response to the GH EDCTP3 call for support to EDCTP Africa Office (AO), which is part of the EDCTP Association Secretariat, based in Cape Town and hosted by the South African Medical Research Council. The aim of the proposal is to provide support for the operation of the AO to ensure optimal implementation and visibility of the GH EDCTP3 programme in SSA. The AO will provide technical support, promote networking activities (South-North, South–South), ensure alignment of the funded activities, strategic partnerships, and increase visibility of the GH EDCTP3. This aim of the project will be achieved through several activities that include technical support for the design, implementation and monitoring of capacity developing activities, monitoring funded projects, organising workshops, and facilitating dialogue between African and European research entities and stakeholders. The expected impact is a strengthened and improved delivery of the GH EDCTP3 programme in SSA. The implementation of this proposed project will be structured into four work packages (WP) called Project management (WP1), Capacity development and networking (WP2), Strategic Partnerships (WP3) and Conferences, forums, and meetings (WP4). Through this grant the AO will contribute to the following impacts: Accelerated product development for fighting target infectious diseases; Facilitated preparedness against public health emergencies in line with One Health; Increased visibility of AU-EU partnership in science; Ensured close alignment with SSA national research programmes and activities on target diseases and R&I; Increased participation of SSA countries in GH EDCTP3; and Increased participation of industry and private entities in product development and clinical trials in SSA.
To implement the project fully the AO will need a competent Project Coordinator, four Project Officers, a Senior Administrative Officer and an Office Manager. The project will be 2,953,000 euros.

Coordinator

EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP
Net EU contribution
€ 2 953 000,00
Address
ANNA VAN SAKSENLAAN 51
2593 HW Den Haag
Netherlands

See on map

Region
West-Nederland Zuid-Holland Agglomeratie ’s-Gravenhage
Activity type
Research Organisations
Links
Total cost
€ 3 691 250,00